CGRP and migraine: from bench to bedside

Migraine treatment has reached a new era with the development of drugs that target the trigeminal neuropeptide calcitonin gene-related peptide (CGRP) or its receptor. The CGRP related therapies offer considerable improvements over existing drugs as they are the first to be designed to act on the tri...

Full description

Saved in:
Bibliographic Details
Published in:Revue neurologique Vol. 177; no. 7; pp. 785 - 790
Main Author: Edvinsson, L.
Format: Journal Article
Language:English
Published: France Elsevier Masson SAS 01.09.2021
Subjects:
ISSN:0035-3787
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first